- Conditions
- Type 1 Diabetes Mellitus
- Interventions
- Fiasp®, Novolog®, 670G hybrid closed loop continuous subcutaneous insulin infusion system
- Drug · Device
- Lead sponsor
- Texas Diabetes & Endocrinology, P.A.
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 40 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2020
- U.S. locations
- 1
- States / cities
- Austin, Texas
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–3
of 3
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Type 1 Diabetes, Type 2 Diabetes
- Interventions
- I-PORT, standard injections
- Device · Other
- Lead sponsor
- Texas Diabetes & Endocrinology, P.A.
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 31 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2011
- U.S. locations
- 1
- States / cities
- Austin, Texas
- Conditions
- Other Endocrine/Nutritional/Metabolic Disorder
- Interventions
- Nutritional Supplement Blend
- Dietary Supplement
- Lead sponsor
- Pharmanex
- Industry
- Eligibility
- 30 Years to 70 Years
- Enrollment
- 41 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2015 – 2016
- U.S. locations
- 2
- States / cities
- Austin, Texas • Logan, Utah